Sector: MedicalJAVELIN PHARMACEUTIC (AMEX: JAV)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 26 |
Technical : | 99 |
Performance : | 223 |
Overall: | 88 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 207 |
Technical : | 303 |
Performance : | 289 |
Overall: | 296 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 207 |
Technical : | 268 |
Performance : | 301 |
Overall: | 293 |
Number of Stocks: | 306 |
Headlines
- Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 Results
Nov 10, 2009 07:00 AM | JAV
- Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results
Nov 04, 2009 09:15 AM | JAV
- Javelin Pharmaceuticals, Inc. Tops Up Balance Sheet Through Registered Direct Offering
Oct 30, 2009 09:25 AM | JAV
- Pain for Pleasure with Javelin Pharmaceuticals (AMEX:JAV)
Aug 06, 2009 09:32 AM | JAV
- Extreme FDA Calendar Trades: 20 Stocks Under $5
Jul 21, 2009 08:52 AM | ADLS, APPA, APPY, ARNA, COV, CRXX
- FDA Calendar Updates: ACUR, BSX, JAV, KG
Jun 23, 2009 11:40 AM | ACUR, BSX, JAV, KG
- FDA Calendar Updates: Transdel (OTC:TDLP), Javelin (AMEX:JAV), Jazz Pharma (NASDAQ:JAZZ)
Jun 15, 2009 12:42 PM | JAV, JAZZ
- In Search of Healthcare Diamonds In The Rough
Jan 12, 2009 12:57 AM | ACHN, AKRX, BPA, CYNO, DNA, ENDP
- Nine For '09: Stock Picks For The New Year
Dec 10, 2008 11:23 PM | AAPL, BBA, CELG, CMED, JAV, KFT
- Eyeing Opportunities In Micro-Cap Bio-Pharma Index
Dec 02, 2008 09:54 AM | ACHN, ACUS, ADLR, AKRX, BDSI, BMY
- Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain
Aug 11, 2009 08:36 AM | JAV
- Javelin Pharmaceuticals, Inc. Reports Second Quarter 2009 Results and Corporate Highlights
Aug 11, 2009 07:56 AM | JAV
- Javelin Pharmaceuticals to Host Second Quarter 2009 Conference Call
Aug 04, 2009 08:38 AM | JAV
- IP Advocate Enhances Interactive IPAO Forum With New ˜Expert Opinions' Section
Jul 14, 2009 06:56 AM | JAV
- Javelin Pharmaceuticals Completes Open Label Safety Study of Dyloject™ -
Jun 23, 2009 07:24 AM | JAV
- New Study Shows Javelin Pharmaceutical’s DylojectTM Well-Tolerated in High-Risk Patients with Impaired Renal and Hepatic Function
Jun 15, 2009 08:51 AM | JAV
- Javelin Pharmaceuticals, Inc. Reports First Quarter 2009 Results and Corporate Highlights
May 07, 2009 07:30 AM | JAV
- Javelin Pharmaceuticals to Announce First Quarter 2009 Financial Results
May 04, 2009 05:54 PM | JAV
- Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2008
Mar 12, 2009 07:02 AM | JAV
- Javelin Pharmaceuticals Quarterly Conference Call Invitation
Mar 05, 2009 04:17 PM | JAV
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
JAV
|
Compare to S&P
|
| YTD |
17.60 %
|
-2.67 %
|
| 4 Weeks |
-5.16 %
|
-6.18 %
|
| 12 Weeks |
-20.54 %
|
-25.09 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 15.38 %
|
|
EPS Growth in Last Year: 38.89 %
|
|
Sales Growth in Last Quarter: 275.75 %
|
|
Sales Growth in Last Quarter: 209.02 %
|
|
